Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice.
暂无分享,去创建一个
[1] Wei Wang,et al. Bell-shaped D-serine actions on hippocampal long-term depression and spatial memory retrieval. , 2008, Cerebral cortex.
[2] S. Floresco,et al. Disruption of AMPA Receptor Endocytosis Impairs the Extinction, but not Acquisition of Learned Fear , 2008, Neuropsychopharmacology.
[3] J. Krystal,et al. A Meta-Analysis of D-Cycloserine and the Facilitation of Fear Extinction and Exposure Therapy , 2008, Biological Psychiatry.
[4] Trevor Archer,et al. Nitric oxide synthase inhibition attenuates phencyclidine-induced disruption of cognitive flexibility , 2008, Pharmacology Biochemistry and Behavior.
[5] Eric R. Kandel,et al. Transgenic Mice Lacking NMDAR-Dependent LTD Exhibit Deficits in Behavioral Flexibility , 2008, Neuron.
[6] J. Roder,et al. D-Serine Augments NMDA-NR2B Receptor-Dependent Hippocampal Long-Term Depression and Spatial Reversal Learning , 2008, Neuropsychopharmacology.
[7] P. Fletcher,et al. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1‐targeted mice , 2008, Genes, brain, and behavior.
[8] Joseph E LeDoux,et al. Acquisition of Fear Extinction Requires Activation of NR2B-Containing NMDA Receptors in the Lateral Amygdala , 2007, Neuropsychopharmacology.
[9] M. Matsushita,et al. A Genetic Variant of the Serine Racemase Gene Is Associated with Schizophrenia , 2007, Biological Psychiatry.
[10] JaneR . Taylor,et al. Molecular mechanisms of memory reconsolidation , 2007, Nature Reviews Neuroscience.
[11] Bruno Giros,et al. Parallel Loss of Hippocampal LTD and Cognitive Flexibility in a Genetic Model of Hyperdopaminergia , 2007, Neuropsychopharmacology.
[12] D. Hampson,et al. Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] Karim Nader,et al. NMDA receptors are critical for unleashing consolidated auditory fear memories , 2006, Nature Neuroscience.
[14] Rick Richardson,et al. Effects of D-Cycloserine on Extinction: Translation From Preclinical to Clinical Work , 2006, Biological Psychiatry.
[15] J. Mothet,et al. d-Serine signalling in the brain: friend and foe , 2006, Trends in Neurosciences.
[16] C. Chiu,et al. Behavioral and biochemical characterization of a mutant mouse strain lacking d-amino acid oxidase activity and its implications for schizophrenia , 2006, Molecular and Cellular Neuroscience.
[17] S. Mariotto,et al. Mutual regulation between serine and nitric oxide metabolism in human glioblastoma cells , 2006, Neuroscience Letters.
[18] C. Palm,et al. Preferred stereoselective brain uptake of d-serine--a modulator of glutamatergic neurotransmission. , 2005, Nuclear medicine and biology.
[19] K. Summer,et al. D-amino-acid oxidase is involved in D-serine-induced nephrotoxicity. , 2005, Chemical research in toxicology.
[20] J. Roder,et al. Effects of the rd1 Mutation and Host Strain on Hippocampal Learning in Mice , 2005, Behavior genetics.
[21] M. Maekawa,et al. Spatial learning and long-term potentiation of mutant mice lacking d-amino-acid oxidase , 2005, Neuroscience Research.
[22] L. Klomp,et al. D-amino acids in the central nervous system in health and disease. , 2005, Molecular genetics and metabolism.
[23] K. Hashimoto,et al. Reduced d-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[24] R. Richardson,et al. d-cycloserine facilitates extinction of learned fear: Effects on reacquisition and generalized extinction , 2005, Biological Psychiatry.
[25] Daniel C. Javitt,et al. D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia , 2005, Biological Psychiatry.
[26] M. Millan. N-Methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives , 2005, Psychopharmacology.
[27] R. Panizzutti,et al. Serine Racemase Modulates Intracellular D-Serine Levels through an α,β-Elimination Activity* , 2005, Journal of Biological Chemistry.
[28] Barbara O Rothbaum,et al. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear. , 2004, Archives of general psychiatry.
[29] B. Pouzet,et al. Spatial Memory Deficits Induced by Perinatal Treatment of Rats with PCP and Reversal Effect of D-Serine , 2004, Neuropsychopharmacology.
[30] J. Coyle,et al. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia , 2004, Psychopharmacology.
[31] Denise Manahan-Vaughan,et al. Hippocampal long-term depression and long-term potentiation encode different aspects of novelty acquisition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[32] S. Barger,et al. Induction of serine racemase expression and D-serine release from microglia by amyloid β-peptide , 2004, Journal of Neuroinflammation.
[33] S. Cichon,et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder , 2004, Molecular Psychiatry.
[34] R. Joosten,et al. The NMDA-receptor antagonist MK-801 selectively disrupts reversal learning in rats , 2003, Neuroreport.
[35] M. Poo,et al. Contribution of astrocytes to hippocampal long-term potentiation through release of d-serine , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] Kenji Hashimoto,et al. Decreased serum levels of D-serine in patients with schizophrenia: evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. , 2003, Archives of general psychiatry.
[37] A. Pack,et al. Sleep deprivation selectively impairs memory consolidation for contextual fear conditioning. , 2003, Learning & memory.
[38] R. Nicoll,et al. Expression mechanisms underlying long-term potentiation: a postsynaptic view. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[39] J. Kemp,et al. Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition , 2003, Neuropharmacology.
[40] M. Caron,et al. Differential Mechanisms of Morphine Antinociceptive Tolerance Revealed in βArrestin-2 Knock-Out Mice , 2002, The Journal of Neuroscience.
[41] G. Wong. Speed congenics: Applications for transgenic and knock-out mouse strains , 2002, Neuropeptides.
[42] Hongkui Zeng,et al. Forebrain-Specific Calcineurin Knockout Selectively Impairs Bidirectional Synaptic Plasticity and Working/Episodic-like Memory , 2001, Cell.
[43] R. Konno,et al. Exaggerated responses to chronic nociceptive stimuli and enhancement of N-methyl-d-aspartate receptor-mediated synaptic transmission in mutant mice lacking d-amino-acid oxidase , 2001, Neuroscience Letters.
[44] D. Linden,et al. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[45] A. Belger,et al. Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions , 2000, Biological Psychiatry.
[46] E. Shimizu,et al. Genetic enhancement of learning and memory in mice , 1999, Nature.
[47] D. Manahan‐Vaughan,et al. Novelty acquisition is associated with induction of hippocampal long-term depression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[48] R Hen,et al. 5-HT1B Receptor Knock-Out Mice Exhibit Increased Exploratory Activity and Enhanced Spatial Memory Performance in the Morris Water Maze , 1999, The Journal of Neuroscience.
[49] T. Robbins,et al. Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage , 1999, Schizophrenia Research.
[50] P. Holland,et al. Hippocampus and context in classical conditioning , 1999, Current Opinion in Neurobiology.
[51] R. Nardacci,et al. Immunocytochemical localization of d-amino acid oxidase in rat brain , 1999, Journal of neurocytology.
[52] K N Sheth,et al. Purification of serine racemase: biosynthesis of the neuromodulator D-serine. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[53] Nicholas Lange,et al. D-serine added to antipsychotics for the treatment of schizophrenia , 1998, Biological Psychiatry.
[54] Hongjoo J. Lee,et al. Amygdalar NMDA Receptors are Critical for New Fear Learning in Previously Fear-Conditioned Rats , 1998, The Journal of Neuroscience.
[55] J. Takahashi,et al. Automated measurement of mouse freezing behavior and its use for quantitative trait locus analysis of contextual fear conditioning in (BALB/cJ x C57BL/6J)F2 mice. , 1998, Learning & memory.
[56] S. Snyder,et al. d-Serine as a Neuromodulator: Regional and Developmental Localizations in Rat Brain Glia Resemble NMDA Receptors , 1997, The Journal of Neuroscience.
[57] E. Kehoe,et al. MK-801 protects conditioned responses from extinction in the rabbit nictitating membrane preparation , 1996, Psychobiology.
[58] K. Wada,et al. Functional Comparison of d‐Serine and Glycine in Rodents: The Effect on Cloned NMDA Receptors and the Extracellular Concentration , 1995, Journal of neurochemistry.
[59] S. Snyder,et al. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[60] J. Krystal,et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.
[61] T. Nishikawa,et al. Free d-serine, d-aspartate and d-alanine in central nervous system and serum in mutant mice lacking d-amino acid oxidase , 1993, Neuroscience Letters.
[62] R. Konno,et al. A single-base-pair substitution abolishes D-amino-acid oxidase activity in the mouse. , 1992, Biochimica et biophysica acta.
[63] K. Abe,et al. Involvement of glycine site associated with the NMDA receptor in hippocampal long-term potentiation and acquisition of spatial memory in rats , 1992, Brain Research.
[64] D. Javitt,et al. Recent advances in the phencyclidine model of schizophrenia. , 1991, The American journal of psychiatry.
[65] J. D. Clements,et al. Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-d-aspartate receptor , 1991, Neuron.
[66] P. Ascher,et al. Glycine potentiates the NMDA response in cultured mouse brain neurons , 1987, Nature.
[67] R. Konno,et al. Mouse mutant deficient in D-amino acid oxidase activity. , 1983, Genetics.
[68] James L McGaugh,et al. The role of NMDA glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of conditioned fear , 2003, Hippocampus.
[69] P. Sham,et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. , 2002, Nature Reviews Genetics.
[70] I. Whishaw,et al. Perseveration on place reversals in spatial swimming pool tasks: Further evidence for place learning in hippocampal rats , 1997, Hippocampus.
[71] J. Sirviö,et al. The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats , 1995, Journal of neural transmission. Parkinson's disease and dementia section.